Trend Results : The Cancer


Blog Post Results (1-20 of 10000+)

FILTER RESULTS

Nanopolymer PolyGPA Can Detect Elusive Bladder Cancer Biomarker

4 minutes agoIndustries / Medical : medGadget

Researchers have created a new technique to detect glycoproteins in biological fluids. The Purdue University team engineered an array they called polyGPA (polymer-based reverse phase glycoprotein array) and have shown proof-of-concept...Show More Summary

Global public health advocates open new fronts in war on tobacco

(International Association for the Study of Lung Cancer) Efforts to control tobacco as a public health threat have escalated as clinicians and public health advocates have coalesced to beat back threats from tobacco companies through public advocacy, public health, and pension reform. Show More Summary

2016 was jinxed by karmic voodoo but never thought I'd live to see it

Death has been relentless this year, with one quite important exception – me. When I was diagnosed with cancer 10 years ago, the worst case scenario was ‘dead by Christmas 2006’ What a great year 2016 was. It was a tremendous year, full of hope. Show More Summary

Childhood Cancer Leader Joins MD Anderson to Lead Pediatrics

Richard Gorlick, M.D., an internationally recognized expert in pediatric oncology and hematology, today joined The University of Texas MD Anderson Children's Cancer Hospital as the division head and department chair of Pediatrics.

Leukemia drug combo is encouraging in early Phase I clinical trial

(Columbia University Medical Center) In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the responders had relapsed after treatment with decitabine alone.

Drug combination yields results in patients with forms of leukemia or lymphoma

(Dana-Farber Cancer Institute) A combination of two targeted agents -- one approved by the Food and Drug Administration and one undergoing testing -- has demonstrated safety as well as encouraging signs of effectiveness in a phase 1 clinical trial in patients with relapsed or hard-to-treat chronic lymphocytic leukemia or mantle cell lymphoma.

The Neediest Cases: Despite Cancer Diagnosis and Husband’s Death, Keeping a Positive Outlook

2 hours agoNews : NYTimes: News

Gertrudis Torres said her son and daughter have given her motivation to beat the disease, even as her substantial grief and her weakened physical strength made the challenge seem impossible at times.

Forget those occasional cigarettes: There is no safe smoking level

2 hours agoHealth : The Checkup

New study finds that smoking even just a few times a week raises the risk of dying of lung cancer and other causes

AbbVie and Johns Hopkins to Collaborate on Cancer Research

North Chicago, Ill. and Baltimore, Md. December 5, 2016 - AbbVie (NYSE: ABBV), a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a five-year collaboration agreement with the goal of advancing medical oncology research and discovery at both organizations.

Mayo Clinic Radio: Novel cancer therapies / point-of-care ultrasound / winter skin care

Skin cancer is the most common form of cancer in the U.S., and the deadliest form of skin cancer is melanoma. The Melanoma Research Laboratory at Mayo Clinic is working to improve survival rates by developing novel treatments for metastatic melanoma. On the next Mayo Clinic Radio program, Dr. Svetomir Markovic, director of the lab, will […]

UAMS Myeloma Institute Collaborates to Compile High-Quality Genetic Data

The University of Arkansas for Medical Sciences (UAMS) is collaborating with Dana-Farber Cancer Institute and Celgene Corp. to compile the largest set of high-quality

Leukemia Drug Combo Is Encouraging in Early Phase I Clinical Trial

In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the responders had relapsed after treatment with decitabine alone.

Live longer by eating nuts

Just 1 oz a day reduces risk of cancer and heart disease. Analysis suggests even a small daily serving cuts the risk of coronary heart disease by 30 per cent, cancer by 15 per cent and premature death by 22 per cent. It can also halve the risk of respiratory disease and reduces diabetes by [...]

Researchers uncover protein-based 'cancer signature'

(University of Basel) A research team at the University of Basel's Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. As the researchers report in Genome Biology this 'cancer signature' could potentially be used to predict the progression of the disease.

Advocacy and community health care models complement research and clinical care

(International Association for the Study of Lung Cancer) Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the first day of the IASLC 17th World Conference on Lung Cancer in Vienna, Austria.

CPX-351 improves survival following allogeneic hematopoietic cell transplant in older high-risk acute myeloid leukemia patients

(H. Lee Moffitt Cancer Center & Research Institute) Acute myeloid leukemia, or AML, is a type of cancer of the blood and bone marrow. It occurs most often in older populations and progresses rapidly, interfering with the production of red blood cells, white blood cells and platelets. Treatments include chemotherapy, drug therapy and stem-cell transplants.

Moffitt Cancer Center study shows improved response rates in myelodysplastic syndromes patients treated with lenalidomide and epoetin alpha

(H. Lee Moffitt Cancer Center & Research Institute) Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia. Show More Summary

Tracking Down One of Cancer's Deadliest Culprits, the Ras Family of Genes

3 hours agoNews : Newsweek: US

When it comes to the current state of cancer survival, Susan Bates feels like many of the rest of us. “It’s incredibly frustrating,” she says. For Bates, who treats pancreatic and other cancers at Columbia University Medical Center,Show More Summary

A Message to President-Elect Trump

This month, I thought I would be writing about presenting an agenda to President-elect Clinton's transition team, with our suggestions for a plan to end breast cancer. As a staunch supporter of the National Breast Cancer Coalition'sShow More Summary

Researchers uncover protein-based 'cancer signature'

A research team has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. This “cancer signature” could potentially be used to predict the progression of the disease.

Copyright © 2015 Regator, LLC